A reliable tool to determine cell viability in complex 3-D culture: The acid phosphatase assay

被引:172
作者
Friedrich, Juergen
Eder, Wolfgang
Castaneda, Juana
Doss, Markus
Huber, Elisabeth
Ebner, Reinhard
Kunz-Schughart, Leoni A.
机构
[1] Tech Univ Dresden, Fac Med Carl Gustav Carus, Ctr Radiat Res Oncol, D-01307 Dresden, Germany
[2] Univ Regensburg, Inst Pathol, D-8400 Regensburg, Germany
关键词
cell-based assay; 3-D culture; spheroid; antitumor drug testing; cell viability;
D O I
10.1177/1087057107306839
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cell-based assays are more complex than cell-free test systems but still reflect a highly artificial cellular environment. Incorporation of organotypic 3-dimensional (3-D) culture systems into mainstream drug development processes is increasingly discussed but severely limited by complex methodological requirements. The objective of this study was to explore a panel of standard assays to provide an easy-handling, standardized protocol for rapid routine analysis of cell survival in multicellular tumor spheroid-based antitumor drug testing. Spheroids of 2 colon carcinoma cell lines were characterized for evaluation. One of the assay systems tested could reliably be used to determine cell viability in spheroids. The authors verified that the acid phosphatase assay (APH) is applicable for single spheroids in 96-well plates, does not require spheroid dissociation, and is linear and highly sensitive for HT29 and HCT-116 spheroids up to diameters of 650 mu m and 900 gm, consisting of 40,000 and 80,000 cells, respectively. Treatment of HT29 and HCT-116 cells with 5-fluorouracil, Irinotecan, and C-1311 revealed critically reduced drug efficacies in 3-D versus monolayer culture, which is discussed in light of literature data. The experimental protocol presented herein is a small but substantial contribution to the establishment of sophisticated 3-D in vitro systems in the antitumor drug screening scenario.
引用
收藏
页码:925 / 937
页数:13
相关论文
共 54 条
[1]   Imidazoacridinones arrest cell-cycle progression in the G2 phase of L1210 cells [J].
Augustin, E ;
Wheatley, DN ;
Lamb, J ;
Konopa, J .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 (01) :39-44
[2]  
BARONE RM, 1981, CANCER, V47, P2348
[3]   Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer [J].
Burger, AM ;
Double, JA ;
Konopa, J ;
Bibby, MC .
BRITISH JOURNAL OF CANCER, 1996, 74 (09) :1369-1374
[4]   Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311 [J].
Burger, AM ;
Jenkins, TC ;
Double, JA ;
Bibby, MC .
BRITISH JOURNAL OF CANCER, 1999, 81 (02) :367-375
[5]  
CARLSSON J, 1984, RECENT RESULTS CANC, V95, P1
[6]   Mechanism of LIGHT/Interferon-γ-induced cell death in HT-29 cells [J].
Chang, YH ;
Chao, Y ;
Hsieh, SL ;
Lin, WW .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 93 (06) :1188-1202
[7]  
CHAU M, 2006, 2006 AM ASS CAN RES
[8]   Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours [J].
Chignola, R ;
Schenetti, A ;
Andrighetto, G ;
Chiesa, E ;
Foroni, R ;
Sartoris, S ;
Tridente, G ;
Liberati, D .
CELL PROLIFERATION, 2000, 33 (04) :219-229
[9]   A new synthetic agent with potent but selective cytotoxic activity against cancer [J].
Cholody, WM ;
Kosakowska-Cholody, T ;
Hollingshead, MG ;
Hariprakasha, HK ;
Michejda, CJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (13) :4474-4481
[10]   8-SUBSTITUTED 5-[(AMINOALKYL)AMINO]-6H-V-TRIAZOLO[4,5,1-DE]ACRIDIN-6-ONES AS POTENTIAL ANTINEOPLASTIC AGENTS - SYNTHESIS AND BIOLOGICAL-ACTIVITY [J].
CHOLODY, WM ;
MARTELLI, S ;
KONOPA, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) :2852-2856